Literature DB >> 9169425

Effects of intracellular tyrosine residue mutation and carboxyl terminus truncation on signal transduction and internalization of the rat bradykinin B2 receptor.

G N Prado1, L Taylor, P Polgar.   

Abstract

Presently, little is known of the amino acid motif(s) participating in bradykinin B2 receptor-mediated signal transduction processes. In this report we investigate the potential role of the two existing tyrosine (Tyr) residues in the intracellular regions and the carboxyl terminus in the regulatory function of this receptor. Rat-1 cells, which do not contain detectable bradykinin B2 receptor, were transfected with wild type and mutant receptor cDNAs. Tyr-131 and Tyr-321 were each mutated to corresponding alanine-, serine-, and phenylalanine-containing sequences. The last 34 amino acid residues of the carboxyl terminus were truncated. Rat-1 cells transfected with the mutant forms of the receptor cDNA including the truncated COOH-terminal cDNA all bound [3H]bradykinin with essentially the same Kd of approximately 2.2 nM as cells transfected with the wild type bradykinin B2 receptor. However, mutating Tyr-131 resulted in important changes in bradykinin-stimulated phosphoinositide turnover and arachidonate release. For example, exchanging Tyr-131 for alanine led to an 80% decreased arachidonate release (p < 0.005), 90% decrease in inositol phosphate (IP) accumulation (p < 0.001), with receptor uptake at 15 min remaining essentially unchanged. Mutating the same Tyr to phenylalanine resulted in unchanged bradykinin-stimulated IP accumulation, only a slightly lowered arachidonate release, and unchanged receptor uptake at 15 min. Mutating Tyr-321 to alanine resulted in a very different pattern. There was a small but significant reduction in arachidonate release (p < 0.03) and IP accumulation (p < 0.008) with a large, 30%, increase in receptor uptake at 15 min (p < 0.010). Truncation of a portion of the carboxyl tail also proved meaningful, with a 60% decrease in arachidonate release and an 80% decrease in IP accumulation. The truncation also resulted in a large, 130%, decrease in receptor uptake at 15 min (p < 0.023). Taken together, these results point to Tyr-131 as an important element in determining bradykinin-stimulated arachidonate release and IP accumulation. Tyrosine phosphorylation at this site apparently does not play a major role. Tyr-131, Tyr-321, and the carboxyl tail appear to be important in determining receptor uptake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169425     DOI: 10.1074/jbc.272.23.14638

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.

Authors:  Satya P Singh; John F Foley; Hongwei H Zhang; Darrell E Hurt; Jennifer L Richards; Craig S Smith; Fang Liao; Joshua M Farber
Journal:  Mol Pharmacol       Date:  2015-08-27       Impact factor: 4.436

2.  Interactions between histamine and bradykinin in stimulation of ischaemically sensitive cardiac afferents in felines.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

3.  Transgenic expression of an altered angiotensin type I AT1 receptor resulting in marked modulation of vascular type I collagen.

Authors:  Jun Yu; Linda Taylor; Celeste Rich; Paul Toselli; Philip Stone; Daniel Green; Rod Warburton; Nicholas Hill; Ronald Goldstein; Peter Polgar
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

4.  Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.

Authors:  C Robert; D Pruneau; J-L Paquet
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors.

Authors:  Xianming Zhang; Jessica L Lowry; Viktor Brovkovych; Randal A Skidgel
Journal:  Cell Signal       Date:  2012-04-12       Impact factor: 4.315

6.  Limiting angiotensin II signaling with a cell-penetrating peptide mimicking the second intracellular loop of the angiotensin II type-I receptor.

Authors:  Jun Yu; Linda Taylor; Dale Mierke; Eric Berg; Michael Shia; Jordan Fishman; Christine Sallum; Peter Polgar
Journal:  Chem Biol Drug Des       Date:  2010-05-18       Impact factor: 2.817

7.  Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant.

Authors:  Saad Ahmad; Francesca Cesana; Edward Lamperti; Haralambos Gavras; Jun Yu
Journal:  Am J Hypertens       Date:  2009-09-24       Impact factor: 2.689

8.  Phosphorylation inactivation of endothelial nitric oxide synthesis in pulmonary arterial hypertension.

Authors:  Sudakshina Ghosh; Manveen Gupta; Weiling Xu; Deloris A Mavrakis; Allison J Janocha; Suzy A A Comhair; Mohammad Mahfuzul Haque; Dennis J Stuehr; Jun Yu; Peter Polgar; Sathyamangla V Naga Prasad; Serpil C Erzurum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-29       Impact factor: 5.464

9.  Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling.

Authors:  Xianming Zhang; Viktor Brovkovych; Yongkang Zhang; Fulong Tan; Randal A Skidgel
Journal:  Cell Signal       Date:  2014-10-05       Impact factor: 4.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.